APA Alıntı

Panaccione, R., Colombel, J., Travis, S. P. L., Bossuyt, P., Baert, F., Vaňásek, T., . . . D’Haens, G. R. (2020). Tight control for Crohn’s disease with adalimumab-based treatment is cost-effective: An economic assessment of the CALM trial. Gut.

Chicago Stili Alıntı

Panaccione, Remo, et al. "Tight Control for Crohn’s Disease With Adalimumab-based Treatment Is Cost-effective: An Economic Assessment of the CALM Trial." Gut 2020.

MLA Alıntı

Panaccione, Remo, et al. "Tight Control for Crohn’s Disease With Adalimumab-based Treatment Is Cost-effective: An Economic Assessment of the CALM Trial." Gut 2020.

Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..